4//SEC Filing
Schwabe Stefan K.F. 4
Accession 0001104659-19-010801
CIK 0001356576other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:28 PM ET
Size
6.1 KB
Accession
0001104659-19-010801
Insider Transaction Report
Form 4
Schwabe Stefan K.F.
Executive Vice President R&D
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-02-22+40,000→ 40,000 totalExercise: $36.75Exp: 2029-02-22→ Common Stock (40,000 underlying)
Holdings
- 2,314
Common Stock
Footnotes (2)
- [F1]Includes an aggregate of 347 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
- [F2]The option vests in four equal annual installments beginning on February 22, 2020.
Documents
Issuer
SUPERNUS PHARMACEUTICALS INC
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001557657
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:28 PM ET
- Size
- 6.1 KB